Show results for
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Environmental
- Water and Wastewater
- Automobile & Ground Transport
- Electronics and Computers
- Aerospace & Air Transport
- Commercial
- Waste and Recycling
- Oil, Gas & Refineries
- Agriculture
- Health and Safety
- Government
- Manufacturing, Other
- Food and Beverage
- Energy
- Construction & Construction Materials
Diabetes Type Suppliers Serving Belarus
51 companies found
based inBurgdorf, SWITZERLAND
Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 35 years’ experience. As a leader in innovation and technology, it is a preferred partner of ...
Developed with the aim of optimised communication between people with diabetes and healthcare professionals, the mylife Diabetescare therapy management is an easy-to-use and easy-to-share solution for diabetes therapy data. It consists of the mylife ...
based inMiami, FLORIDA (USA)
At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions. OPKO has grown into a global ...
Oxyntomodulin is a naturally occurring hormone produced in the colon, shown to bind both the GLP-1 and glucagon receptor, regulating both blood glucose appetite and lipid metabolism. OPKO Health is developing OPK88003, a long-acting, once weekly ...
based inBallymena, NORTHERN IRELAND
Neurovalens has designed cranial nerve stimulation technology that accurately and efficiently activates key brainstem neurons without needing implanted electrodes. This non-invasive approach removes the need for surgical implantation and allows much ...
We believe in people and their ability to improve their lives for the ...
based inRother Valley Way, UNITED KINGDOM
Vantage was established in 1988 and quickly became a major provider of customisable data management solutions. We have over 30 years of experience helping organisations in various sectors, including charities, healthcare, local authorities, and many ...
To get an insight into your health and understand the potential risks involved with having type 2 diabetes or obesity, take our 5 minute test ...
based inBlankenfelde-Mahlow, GERMANY
Medipan GmbH was founded in 1992 and is an independent, family company. The company started with the marketing of radioimmunoassays for the characterization of thyroid function, disease and tumor markers, with its partners from nuclear medicine ...
Radio ligand assay for the quantitative determination of autoantibodies to Insulin (IAA) in human ...
based inBagsværd, DENMARK
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. ...
based inCrumlin, UNITED KINGDOM
A global market leader within the in vitro diagnostics industry, Randox Laboratories develops innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. ...
Diabetes is a life-long condition causing blood sugar levels to become too high and affects millions of people worldwide. Whilst the condition cannot be cured, it can be controlled and monitored. Randox diabetes reagents cover a spectrum of ...
based inSeocho-gu, SOUTH KOREA
Taking the first step in 1945, JW Group has found the market for domestic therapeutic drug based on its philosophy of respecting life and pioneering spirit. We are strengthening our global market competitiveness by developing leading health care ...
based inBoston, MASSACHUSETTS (USA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...
based inMalvern, PENNSYLVANIA (USA)
LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers ...
based inExeter, UNITED KINGDOM
Attomarker is a British company focused on nanophotonic biochemical testing. It was founded in 2008, and spun out from Professor Andrew Shaw’s research group at the University of Exeter. It has won numerous prestigious awards for innovation and been ...
Attomarker has developed a technology platform that will measure the concentration of biomarkers in blood samples, but it can be readily extended to saliva or even cerebral spinal fluid. The blood contains many components – biomarkers – ...
based inUrdorf, SWITZERLAND
Securecell AG specializes in pioneering advanced solutions within the biotech and MedTech industries. Their technological innovations focus on automated bioprocessing, high-throughput sampling, and the deployment of digital technologies to enhance ...
Our immense knowledge of connecting expansive bioprocessing systems, microfluidics and documenting processes down to the molecular level led us to solutions that could greatly impact the Artificial Pancreas Device System (APDS) market for a ...
based inLake Bluff, ILLINOIS (USA)
Realize Therapeutics is focused on providing Health Care Practitioners (HCPs) with medical nutrition solutions for their patients suffering from obesity and type 2 diabetes. Realize’s strategy is to develop microbe and endocannabinoid formulations ...
based inMadrid, SPAIN
Novalab - Air Liquide Healthcare España, S.L. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management.. With just a quick glance at your smart phone or watch,† you can know your ...
Introducing the new Dexcom G6 CGM System. Experience the power of what Dexcom G6 can do for you. With the Dexcom G6 Continuous Glucose Monitoring (CGM) System, you have the power to know your glucose number and where it's headed and with no ...
based inTrieste, ITALY
Today Eurospital manufactures and commercializes pharmaceutical products, medical-surgical and diagnostic devices and a completely new line of gluten-free products. Throughout the years it extended its range of action by implementing strategic ...
The identification of tissue transglutaminase as the antigen responsible for endomysial positivity has opened up new horizons for the serological diagnosis of celiac disease. Today the determination of anti-tTG antibodies is the reference test for ...
based inLexington, MASSACHUSETTS (USA)
Fractyl Health is an organ editing metabolic therapeutics company focused on pioneering a new approach to the treatment of Type 2 Diabetes (T2D). Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying ...
Our lead product candidate, the Revita DMR System, or Revita®, is a first-in-class procedural therapy designed to target the duodenum as a root cause of type 2 diabetes. For people with advanced ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
based inConcord, MASSACHUSETTS (USA)
Beta Bionics is proud to be incorporated as a Massachusetts public benefit corporation and certified as a B Corporation. We believe we were one of the first, if not the first medical device company to be doing business as a benefit corporation, and ...
based inMiami Lakes, FLORIDA (USA)
Biorep is ISO 13485 Certified and FDA Registered. As a full-service development firm, Biorep has an exclusive focus on medical products and over 20 years of experience developing medical devices. Biorep enables advancements in medical technologies ...
based inDurham, NORTH CAROLINA (USA)
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable, bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. Humacyte ...
Humacyte’s platform technology has the potential to change the lives of countless people around the world by overcoming the current limitations in existing standards of care. We are leveraging our scalable technology platform to develop ...
